ACELYRIN Shares Are Trading Higher After Wells Fargo Upgraded the Stock From Equal-Weight to Overweight and Maintained Its $13 Price Target.
ACELYRIN Shares Are Trading Higher After Wells Fargo Upgraded the Stock From Equal-Weight to Overweight and Maintained Its $13 Price Target.
沃爾斯·富戈（Wells Fargo）將ACELYRIN股票的評級從“等權重”上調至“超重”，並保持其13美元的目標價後，ACELYRIN股票交易價格上漲了。
ACELYRIN Shares Are Trading Higher After Wells Fargo Upgraded the Stock From Equal-Weight to Overweight and Maintained Its $13 Price Target.
沃爾斯·富戈（Wells Fargo）將ACELYRIN股票的評級從“等權重”上調至“超重”，並保持其13美元的目標價後，ACELYRIN股票交易價格上漲了。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。